samedan logo

home > news > detailed info

Peli BioThermal to Present at LogiPharma Europe

Peli BioThermal

Team to Share Industry Insight at Virtual Conference and Showcase Product Range for Pandemic Response

Peli BioThermal, the global name in temperature controlled packaging, will be attending this year’s virtual LogiPharma Europe event and highlight how products have been adapted to meet the rising requirements of the pharmaceutical sector’s rapid response to the global pandemic.

Dominic Hyde, Vice President of Crēdo™ on Demand at Peli BioThermal, is a key speaker at the virtual event where he will share the latest industry insights with delegates via his presentation taking place on Monday November 9th at 17.00, which will be followed by a live Q&A session.

The Peli BioThermal team will also be available to highlight the company’s growing global network and rental options available through its Crēdo on Demand programme, as well as sharing their extensive expertise with attendees who can visit the company’s virtual booth from November 9 -10th. Pharma customers can register for free via

At the event Peli BioThermal will showcase its parcel and bulk shipper solutions which include an expansion of products adapted to support the safe shipment of Covid-19 approved vaccines and therapies worldwide. Peli BioThermal products on show will include Crēdo™ Cargo, Crēdo™ Xtreme, CoolPall™ Flex alongside Crēdo™ Cube and CoolGuard™ Advance.

Hyde said: “Peli BioThermal is pleased to be playing a pivotal part again at LogiPharma where we will be highlighting how the sector is seeing the rapid adaptation of products to meet the demands of Covid-19 applications.

“We are responding to the increasing requirements to design and develop at speed products which meet and exceed the demands of clinical trials and bulk shipping requirements in which frozen and deep frozen pharma product needs to be transported worldwide quickly and efficiently, whilst ensuring compliance, reducing excursions and giving low total cost of ownership.” Visit to learn more about the wide range of Peli BioThermal products and offerings.

Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.
phone +44 1525 243 770
email Celsius House, The Stanbridge Building, Stanbridge Road, Leighton Buzzard LU7 4QQ
Print this page
Send to a friend
News and Press Releases

Lynparza approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers

Approvals based on the PAOLA-1, PROfound and POLO Phase III trials
More info >>

White Papers

EU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market

PCI Pharma Services

Recently, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) opened an investigation into a patient complaint of mold on paracetamol (acetaminophen) tablets (1). It discovered the product was shipped by sea from India to multiple companies in the UK at temperatures reaching up to 60 degrees Celsius. Labeling for paracetamol tablets typically states they should be kept below 30 degrees Celsius. In addition, MHRA discovered the humidity levels exceeded 80 percent during shipping, which is too high for the packaging that was used.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement